Acebrophylline - Polichem
Alternative Names: HOB-051Latest Information Update: 27 Dec 2019
Price :
$50 *
At a glance
- Originator Polichem
- Developer Hyundai Pharmaceutical; Polichem
- Class Antiasthmatics; Bronchodilators; Small molecules; Xanthines
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bronchitis
Most Recent Events
- 27 Dec 2019 No development reported - Phase-III for Bronchitis in South Korea (PO) (Polichem website, December 2019)
- 27 Dec 2019 No development reported for Bronchitis in China (PO) (Polichem website, December 2019)
- 01 Nov 2015 Phase-III clinical trials in Bronchitis in South Korea (PO, controlled release) (NCT02792946)